Interaction of passive smoking with GST (GSTM1, GSTT1, and GSTP1) genotypes in the risk of cervical cancer in India RC Sobti, S Kaur, P Kaur, J Singh, I Gupta, V Jain, A Nakahara Cancer genetics and cytogenetics 166 (2), 117-123, 2006 | 109 | 2006 |
DNA methylation of hepatitis B virus (HBV) genome associated with the development of hepatocellular carcinoma and occult HBV infection P Kaur, A Paliwal, D Durantel, P Hainaut, JY Scoazec, F Zoulim, I Chemin, ... The Journal of infectious diseases 202 (5), 700-704, 2010 | 89 | 2010 |
Contrasting Impact of DNA Repair Gene XRCC1 Polymorphisms Arg399Gln And Arg194Trp on The Risk of Lung Cancer in the North-Indian Population SS Pachouri, RC Sobti, P Kaur, J Singh DNA and cell biology 26 (3), 186-191, 2007 | 64 | 2007 |
CYP17, SRD5A2, CYP1B1, and CYP2D6 Gene Polymorphisms with Prostate Cancer Risk in North Indian Population RC Sobti, K Onsory, AI Al-Badran, P Kaur, M Watanabe, A Krishan, ... DNA and cell biology 25 (5), 287-294, 2006 | 63 | 2006 |
Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma P Kaur, S Mani, MP Cros, JY Scoazec, I Chemin, P Hainaut, Z Herceg Tumor Biology 33, 325-336, 2012 | 60 | 2012 |
XRCC1 codon 399 and ERCC2 codon 751 polymorphism, smoking, and drinking and risk of esophageal squamous cell carcinoma in a North Indian population RC Sobti, J Singh, P Kaur, SS Pachouri, EA Siddiqui, HS Bindra Cancer genetics and cytogenetics 175 (2), 91-97, 2007 | 56 | 2007 |
RNA-Seq of circulating tumor cells in stage II–III breast cancer JE Lang, A Ring, T Porras, P Kaur, VA Forte, N Mineyev, D Tripathy, ... Annals of surgical oncology 25, 2261-2270, 2018 | 50 | 2018 |
EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer A Ring, P Kaur, JE Lang BMC cancer 20, 1-14, 2020 | 48 | 2020 |
Role of hormonal genes and risk of prostate cancer: gene-gene interactions in a North Indian population RC Sobti, L Gupta, SK Singh, A Seth, P Kaur, H Thakur Cancer genetics and cytogenetics 185 (2), 78-85, 2008 | 45 | 2008 |
Bovine babesiosis due to babesia bigemina haematobiochemical and therapeutic studies GS Aulakh, LD Singla, P Kaur, A Alka The Indian journal of animal sciences 75 (6), 2005 | 41 | 2005 |
Challenges in using liquid biopsies for gene expression profiling TB Porras, P Kaur, A Ring, N Schechter, JE Lang Oncotarget 9 (6), 7036, 2018 | 40 | 2018 |
Hormone receptor-related gene polymorphisms and prostate cancer risk in North Indian population K Onsory, RC Sobti, AI Al-Badran, M Watanabe, T Shiraishi, A Krishan, ... Molecular and cellular biochemistry 314, 25-35, 2008 | 39 | 2008 |
Combined effect of GSTM1, GSTT1 and GSTP1 polymorphisms on histological subtypes of lung cancer RC Sobti, P Kaur, S Kaur, AK Janmeja, SK Jindal, J Kishan, S Raimondi Biomarkers 13 (3), 282-295, 2008 | 39 | 2008 |
Attenuation of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine induced nigrostriatal toxicity in mice by N-acetyl cysteine A Sharma, P Kaur, V Kumar, KD Gill Cellular and molecular biology 53 (1), 48-55, 2007 | 38 | 2007 |
Impact of polymorphism in sulfotransferase gene on the risk of lung cancer SS Pachouri, RC Sobti, P Kaur, J Singh, SK Gupta Cancer genetics and cytogenetics 171 (1), 39-43, 2006 | 38 | 2006 |
Effects of cyclin D1 (CCND1) polymorphism on susceptibility to lung cancer in a North Indian population RC Sobti, P Kaur, S Kaur, J Singh, AK Janmeja, SK Jindal, J Kishan, ... Cancer genetics and cytogenetics 170 (2), 108-114, 2006 | 38 | 2006 |
Cyclin D1 (G870A) polymorphism and risk of cervix cancer: a case control study in north Indian population K Satinder, SR Chander, K Pushpinder, G Indu, J Veena Molecular and cellular biochemistry 315, 151-157, 2008 | 37 | 2008 |
Comparison of TCGA and GENIE genomic datasets for the detection of clinically actionable alterations in breast cancer P Kaur, TB Porras, A Ring, JD Carpten, JE Lang Scientific reports 9 (1), 1482, 2019 | 31 | 2019 |
A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix® PC1 System EN Cohen, G Jayachandran, RG Moore, M Cristofanilli, JE Lang, ... Cancers 14 (21), 5238, 2022 | 30 | 2022 |
The epigenome as a potential mediator of cancer and disease prevention in prenatal development P Kaur, LE Shorey, E Ho, RH Dashwood, DE Williams Nutrition reviews 71 (7), 441-457, 2013 | 30 | 2013 |